niacinamide has been researched along with Mouth Neoplasms in 9 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Mouth Neoplasms: Tumors or cancer of the MOUTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim was to establish the pharmacokinetic profiles and their reproducibility during repeated administration, the maximum tolerated dose with fractionated radiotherapy, whether such a dose achieves sufficiently high plasma levels for radiosensitization, the optimal time interval between nicotinamide and irradiation, and toxic side effects." | 2.68 | Administration of nicotinamide during chart: pharmacokinetics, dose escalation, and clinical toxicity. ( Dennis, MF; Hall, DW; Hoskin, PJ; Rojas, A; Saunders, MI; Stratford, MR, 1995) |
| "To characterize oral skin cancer chemoprophylaxis education for acitretin and nicotinamide among current MSDO fellows and to compare the clinical indications felt most appropriate for prescribing to a previously published expert consensus." | 1.91 | Education and Perspectives on the Use of Oral Skin Cancer Chemoprophylaxis: A Cross-Sectional Survey of Current Fellows in Mohs Micrographic Surgery & Dermatologic Oncology. ( Guzman, AK; Ruiz, ES; Schmults, CD, 2023) |
| "Oral squamous cell carcinoma often causes bone invasion resulting in poor prognosis and affects the quality of life for patients." | 1.42 | Synergistic Effect of Sorafenib and Radiation on Human Oral Carcinoma in vivo. ( Chang, B; Chen, JC; Chiang, IT; Hsu, FT; Hwang, JJ; Kwang, WK; Liu, YC, 2015) |
| " It is our conclusion that radiotherapy combined with carbogen and nicotinamide is a safe treatment with manageable side effects." | 1.29 | Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity. ( Kaanders, JH; Marres, HA; Pop, LA; van Daal, WA; van der Kogel, AJ; van der Maazen, RW, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, W | 1 |
| Jing, Y | 1 |
| Wang, S | 1 |
| Wu, Y | 1 |
| Sun, Y | 1 |
| Zhuang, J | 1 |
| Huang, X | 1 |
| Chen, S | 1 |
| Zhang, X | 1 |
| Song, Y | 1 |
| Hu, Q | 1 |
| Ni, Y | 1 |
| Guzman, AK | 1 |
| Schmults, CD | 1 |
| Ruiz, ES | 1 |
| Gao, Y | 1 |
| van Haren, MJ | 1 |
| Moret, EE | 1 |
| Rood, JJM | 1 |
| Sartini, D | 1 |
| Salvucci, A | 1 |
| Emanuelli, M | 1 |
| Craveur, P | 1 |
| Babault, N | 1 |
| Jin, J | 1 |
| Martin, NI | 1 |
| Hsu, FT | 1 |
| Chang, B | 1 |
| Chen, JC | 1 |
| Chiang, IT | 1 |
| Liu, YC | 1 |
| Kwang, WK | 1 |
| Hwang, JJ | 1 |
| Kim, LH | 1 |
| Shin, JA | 1 |
| Jang, B | 1 |
| Yang, IH | 1 |
| Won, DH | 1 |
| Jeong, JH | 1 |
| Chung, TH | 1 |
| Cho, NP | 1 |
| Cho, SD | 1 |
| Hoskin, PJ | 1 |
| Stratford, MR | 1 |
| Saunders, MI | 1 |
| Hall, DW | 1 |
| Dennis, MF | 1 |
| Rojas, A | 1 |
| Kaanders, JH | 1 |
| Pop, LA | 1 |
| Marres, HA | 1 |
| van der Maazen, RW | 1 |
| van der Kogel, AJ | 1 |
| van Daal, WA | 1 |
| Buch, L | 1 |
| Streeter, D | 1 |
| Halpern, RM | 1 |
| Simon, LN | 2 |
| Stout, MG | 1 |
| Smith, RA | 1 |
| Swiatek, KR | 1 |
| Chao, KL | 1 |
1 trial available for niacinamide and Mouth Neoplasms
| Article | Year |
|---|---|
Administration of nicotinamide during chart: pharmacokinetics, dose escalation, and clinical toxicity.
Topics: Aged; Aged, 80 and over; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mouth Neop | 1995 |
8 other studies available for niacinamide and Mouth Neoplasms
| Article | Year |
|---|---|
Identification of Biological Functions and Prognostic Value of NNMT in Oral Squamous Cell Carcinoma.
Topics: Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Niacinamide; Nicotinamid | 2022 |
Education and Perspectives on the Use of Oral Skin Cancer Chemoprophylaxis: A Cross-Sectional Survey of Current Fellows in Mohs Micrographic Surgery & Dermatologic Oncology.
Topics: Acitretin; Cross-Sectional Studies; Curriculum; Education, Medical, Graduate; Educational Status; Fe | 2023 |
Bisubstrate Inhibitors of Nicotinamide
Topics: Antineoplastic Agents; Catalytic Domain; Cell Line, Tumor; Enzyme Inhibitors; Humans; Models, Molecu | 2019 |
Synergistic Effect of Sorafenib and Radiation on Human Oral Carcinoma in vivo.
Topics: Animals; Apoptosis; Bone Neoplasms; Carcinoma, Squamous Cell; Cell Proliferation; Combined Modality | 2015 |
Sorafenib potentiates ABT-737-induced apoptosis in human oral cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Blotting, Western; Cell Line, Tumor; Cell Surv | 2017 |
Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity.
Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Aged, 80 and over; Carbon Dioxide; Ca | 1995 |
Inhibition of transfer ribonucleic acid methylase activity from several human tumors by nicotinamide and nicotinamide analogs.
Topics: Adenocarcinoma; Aldehydes; Amines; Animals; Carbon Isotopes; Carcinoma; Carcinoma 256, Walker; Cell | 1972 |
Nicotinamide methyltransferase and S-adenosylmethionine: 5'-methylthioadenosine hydrolase. Control of transfer ribonucleic acid methylation.
Topics: Animals; Carbon Radioisotopes; Carcinoma; Cell Line; Chromatography, Gel; Chromatography, Thin Layer | 1973 |